105 related articles for article (PubMed ID: 14763)
1. Hazards of non-practolol beta-blockers.
Br Med J; 1977 Feb; 1(6060):529-30. PubMed ID: 14763
[No Abstract] [Full Text] [Related]
2. Practolol and the safety of other beta blockers.
Sutherland DC; Wilson JD
N Z Med J; 1976 Oct; 84(573):282-5. PubMed ID: 12491
[TBL] [Abstract][Full Text] [Related]
3. Letter: Cross-sensitivity between practolol and other beta-blockers?
Zacharias FJ
Br Med J; 1976 May; 1(6019):1213. PubMed ID: 5172
[No Abstract] [Full Text] [Related]
4. Letter: Cross-sensitivity between practolol and other beta-blockers?
Furhoff AK; Nordlander M; Peterson C
Br Med J; 1976 Apr; 1(6013):831. PubMed ID: 4196
[No Abstract] [Full Text] [Related]
5. [Drug eruptions caused by beta-blockers].
Bonnetblanc JM
Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
[TBL] [Abstract][Full Text] [Related]
6. [Adrenergic beta receptor blockaders].
Naess K
Tidsskr Nor Laegeforen; 1975 Feb; 95(6):380-3. PubMed ID: 235805
[No Abstract] [Full Text] [Related]
7. [Therapeutic use of beta blockers in gastroenterology. Gastrointestinal iatrogenic diseases caused by beta blocker use].
De Simone M; Leonardi C; Carbonetti M; Mazzetti di Pietralata M
Minerva Dietol Gastroenterol; 1985; 31(2):245-52. PubMed ID: 2863787
[No Abstract] [Full Text] [Related]
8. [Study of the respiratory tolerance of adrenolytic beta-blockers in the asthmatic].
Hugues FC; Julien D; Munera Y; Marche J
Nouv Presse Med; 1978 Sep; 7(31):2711-5. PubMed ID: 30948
[No Abstract] [Full Text] [Related]
9. [Oculocutaneous reactions following treatment with betablockers].
Erikssen J
Tidsskr Nor Laegeforen; 1976 Aug; 96(24):1288-9. PubMed ID: 9706
[No Abstract] [Full Text] [Related]
10. Drug-induced localized systemic scleroses.
Graham JR
Trans Am Clin Climatol Assoc; 1981; 92():122-32. PubMed ID: 6116306
[No Abstract] [Full Text] [Related]
11. Hypotensive agents, beta-blockers, and drug-induced lupus.
Hughes GR
Br Med J (Clin Res Ed); 1982 May; 284(6326):1358-9. PubMed ID: 6122487
[No Abstract] [Full Text] [Related]
12. [Review: beta-blocking agents in dermatology (author's transl)].
Clerens A; Guilmot-Bruneau MM; Defresne C; Bourlond A
Dermatologica; 1981; 163(1):5-11. PubMed ID: 6115777
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Beta-blockers and the eye.
Br J Ophthalmol; 1976 May; 60(5):311. PubMed ID: 8075
[No Abstract] [Full Text] [Related]
14. [Beta-adrenergic blocking agents and ventilatory function. Clinical aspects].
Monteiro-Trindade A; Costa-Trindade J; Palma-Carlos AG; de Padua F
Cah Med; 1973 Oct; 14(11):949-57. PubMed ID: 4151122
[No Abstract] [Full Text] [Related]
15. Testing times: the emergence of the practolol disaster and its challenge to British drug regulation in the modern period.
Abraham J; Davis C
Soc Hist Med; 2006 Apr; 19(1):127-47. PubMed ID: 17153164
[TBL] [Abstract][Full Text] [Related]
16. Letter: Skin reactions to beta-blockers.
Br Med J; 1975 Mar; 1(5958):626. PubMed ID: 236068
[No Abstract] [Full Text] [Related]
17. Cutaneous side effects from beta-blockers and other antihypertensive agents.
Mobacken H
Acta Med Scand Suppl; 1979; 628():77-80. PubMed ID: 37708
[No Abstract] [Full Text] [Related]
18. Problems with practolol.
Wall-Manning HJ
Drugs; 1975; 10(5-6):336-41. PubMed ID: 1240
[No Abstract] [Full Text] [Related]
19. Letter: Ocular reactions to beta-blockers.
Lyall JR
Br Med J; 1975 Jun; 2(5973):747. PubMed ID: 237597
[No Abstract] [Full Text] [Related]
20. Ocular effects of beta-blocking therapy.
Macrae JA
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(4):510-3. PubMed ID: 31716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
